Literature DB >> 25575135

Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.

Nadia Postupna1, Christopher Dirk Keene, Paul K Crane, Luis F Gonzalez-Cuyar, Joshua A Sonnen, Jessica Hewitt, Samantha Rice, Kimberly Howard, Kathleen S Montine, Eric B Larson, Thomas J Montine.   

Abstract

We used a novel approach to molecular quantification in standard fixed and embedded tissue to measure amyloid β 42 (Aβ(42)) and paired helical filament-τ (PHF-τ) in frontal, temporal, and parietal cortices from 325 consecutive brain autopsies collected as part of a population-based study of brain aging and incident dementia in the Seattle area. We observed significant effects of APOE ε4 on Aβ(42) levels in both diagnostic groups by disease stage and region. In contrast, we did not observe a significant effect of APOE ε4 on PHF-τ levels by disease stage in any region. Levels of Aβ(42) and PHF-τ in cerebral cortex were correlated more strongly in the Dementia group, and these measures had independent explanatory power for dementia beyond those of standard neuropathologic indices. Associations between Lewy body disease and Aβ(42) or PHF-τ levels and between Aβ(42) levels and microvascular brain injury suggested that these comorbid diseases enhanced the penetrance of Alzheimer disease. Our novel approach brings additional insights into the molecular pathogenesis of common causes of dementia and may serve as a platform for future studies pursuing associations between molecular changes in Alzheimer disease and genetic or environmental risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575135      PMCID: PMC4294957          DOI: 10.1097/NEN.0000000000000153

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  35 in total

1.  Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Authors:  Nobuyuki Okamura; Shozo Furumoto; Michelle T Fodero-Tavoletti; Rachel S Mulligan; Ryuichi Harada; Paul Yates; Svetlana Pejoska; Yukitsuka Kudo; Colin L Masters; Kazuhiko Yanai; Christopher C Rowe; Victor L Villemagne
Journal:  Brain       Date:  2014-03-27       Impact factor: 13.501

2.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

5.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

6.  Evaluation of selection bias in an incident-based dementia autopsy case series.

Authors:  Debby Tsuang; Kate L Simpson; Gail Li; Ross L Barnhart; Steven D Edland; James Bowen; Wayne McCormick; Linda Teri; David Nochlin; Eric B Larson; Mary Lou Thompson; James B Leverenz
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Apr-Jun       Impact factor: 2.703

7.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

8.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

9.  Association between lifetime cigarette smoking and lewy body accumulation.

Authors:  Debby Tsuang; Eric B Larson; Ge Li; Jane B Shofer; Kathleen S Montine; Mary Lou Thompson; Joshua A Sonnen; Paul K Crane; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2009-06-15       Impact factor: 6.508

10.  The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).

Authors:  Shannon L Risacher; Sungeun Kim; Li Shen; Kwangsik Nho; Tatiana Foroud; Robert C Green; Ronald C Petersen; Clifford R Jack; Paul S Aisen; Robert A Koeppe; William J Jagust; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Andrew J Saykin
Journal:  Front Aging Neurosci       Date:  2013-04-01       Impact factor: 5.750

View more
  15 in total

1.  Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease.

Authors:  Erica J Melief; Eiron Cudaback; Nikolas L Jorstad; Emily Sherfield; Nadia Postupna; Angela Wilson; Martin Darvas; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  J Neurosci Res       Date:  2015-03-30       Impact factor: 4.164

2.  Multimodal Characterization of the Late Effects of Traumatic Brain Injury: A Methodological Overview of the Late Effects of Traumatic Brain Injury Project.

Authors:  Brian L Edlow; C Dirk Keene; Daniel P Perl; Diego Iacono; Rebecca D Folkerth; William Stewart; Christine L Mac Donald; Jean Augustinack; Ramon Diaz-Arrastia; Camilo Estrada; Elissa Flannery; Wayne A Gordon; Thomas J Grabowski; Kelly Hansen; Jeanne Hoffman; Christopher Kroenke; Eric B Larson; Patricia Lee; Azma Mareyam; Jennifer A McNab; Jeanne McPhee; Allison L Moreau; Anne Renz; KatieRose Richmire; Allison Stevens; Cheuk Y Tang; Lee S Tirrell; Emily H Trittschuh; Andre van der Kouwe; Ani Varjabedian; Lawrence L Wald; Ona Wu; Anastasia Yendiki; Liza Young; Lilla Zöllei; Bruce Fischl; Paul K Crane; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

3.  Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes.

Authors:  Paul K Crane; Rod L Walker; Joshua Sonnen; Laura E Gibbons; Rebecca Melrose; Jason Hassenstab; C Dirk Keene; Nadia Postupna; Thomas J Montine; Eric B Larson
Journal:  Neurobiol Aging       Date:  2016-08-01       Impact factor: 4.673

4.  Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.

Authors:  Margaret E Flanagan; Eric B Larson; Rod L Walker; C Dirk Keene; Nadia Postupna; Brenna Cholerton; Joshua A Sonnen; Sascha Dublin; Paul K Crane; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Precision Medicine: Clarity for the Complexity of Dementia.

Authors:  Brenna Cholerton; Eric B Larson; Joseph F Quinn; Cyrus P Zabetian; Ignacio F Mata; C Dirk Keene; Margaret Flanagan; Paul K Crane; Thomas J Grabowski; Kathleen S Montine; Thomas J Montine
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

6.  Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.

Authors:  Jason W Adams; Victor E Alvarez; Jesse Mez; Bertrand R Huber; Yorghos Tripodis; Weiming Xia; Gaoyuan Meng; Caroline A Kubilus; Kerry Cormier; Patrick T Kiernan; Daniel H Daneshvar; Alicia S Chua; Sarah Svirsky; Raymond Nicks; Bobak Abdolmohammadi; Laney Evers; Todd M Solomon; Jonathan D Cherry; Nurgul Aytan; Ian Mahar; Sherral Devine; Sanford Auerbach; Michael L Alosco; Christopher J Nowinski; Neil W Kowall; Lee E Goldstein; Brigid Dwyer; Douglas I Katz; Robert C Cantu; Robert A Stern; Rhoda Au; Ann C McKee; Thor D Stein
Journal:  J Neuropathol Exp Neurol       Date:  2018-09-01       Impact factor: 3.685

7.  Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.

Authors:  Shelly L Gray; Melissa L Anderson; Joseph T Hanlon; Sascha Dublin; Rod L Walker; Rebecca A Hubbard; Onchee Yu; Thomas J Montine; Paul K Crane; Josh A Sonnen; C Dirk Keene; Eric B Larson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.

Authors:  Willa D Brenowitz; C Dirk Keene; Stephen E Hawes; Rebecca A Hubbard; W T Longstreth; Randy L Woltjer; Paul K Crane; Eric B Larson; Walter A Kukull
Journal:  Neurobiol Aging       Date:  2017-01-30       Impact factor: 4.673

Review 9.  Cognitive Impairment in Older Adults and Therapeutic Strategies.

Authors:  Thomas J Montine; Syed A Bukhari; Lon R White
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

10.  Fine Particulate Matter and Markers of Alzheimer's Disease Neuropathology at Autopsy in a Community-Based Cohort.

Authors:  Rachel M Shaffer; Ge Li; Sara D Adar; C Dirk Keene; Caitlin S Latimer; Paul K Crane; Eric B Larson; Joel D Kaufman; Marco Carone; Lianne Sheppard
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.